Dublin, November 24, 2021--(Business Wire)--"U.S. hospital surgical gowns by type (surgical gowns, non-surgical gowns, patient gowns) and availability (disposable surgical gowns, reusable surgical gowns) Market size, share and trend analysis report"), forecast by risk type and market segment, 2021-2028" report has been added to ResearchAndMarkets.com's products.
It is estimated that by 2028, the size of the US hospital medical clothing market will reach 2.47 billion U.S. dollars, with a compound annual growth rate of 11.90%.
The rising incidence of hospital-acquired infections (HAI), the impact of the COVID-19 outbreak, and the increase in the number of surgical procedures are key factors driving market growth.
The recent outbreak of COVID-19 is expected to have a significant impact on product demand. The pandemic caused by the virus SARS-CoV-2 has greatly increased the demand for medicines, emergency supplies and hospital equipment (including protective clothing, antiseptics and disinfectant products).
The COVID-19 outbreak and the increase in the number of hospitalizations worldwide have significantly increased the demand for hospital gowns in the United States. For example, according to a report issued by the World Health Organization (WHO) in April 2020, there are more than 723,605 existing cases and more than 28,252 new cases in the United States. Confirmed cases
In addition, in order to meet the large domestic demand for medical protective clothing, Ford has begun to use airbag materials to manufacture medical protective clothing. Therefore, the market is expected to grow at a considerable rate during the forecast period.
The WHO calls on industries and governments to increase the production of personal protective equipment by 40%, including hospital protective clothing, gloves, medical masks, masks, aprons, respirators and goggles to meet the growing global demand. It also reported that the increase in demand for these accessories has greatly increased their prices.
For example, the price of surgical masks has risen six times, and the price of hospital gowns has tripled. Therefore, the COVID-19 outbreak has greatly affected the hospital protective clothing market and is considered to be an efficient driving force for this market.
Highlights of the U.S. Hospital Dress Market Report
In terms of revenue, the surgical gown segment accounted for the largest market share in 2019 and is expected to maintain its dominant position during the forecast period due to the increase in the number of surgeries worldwide
The reusable dress part is expected to show the fastest growth during the forecast period. Technologically advanced reusable protective clothing can meet the high demand for hospital protective clothing during a pandemic
Due to the large number of patients suffering from various non-communicable diseases, the low-risk hospital service sector accounted for the largest market share in 2019 and is expected to grow the fastest during the forecast period
Chapter 1 Report Scope 1.1 Market Segmentation and Scope 1.2 Country Scope 1.3 Estimate and Forecast Timeline
Chapter 2 Research Methods 2.1 Research Methods 2.2 Information or Data Analysis 2.3 Market Formulation and Verification 2.4 Country/Region Market Calculation 2.5 Country-based Segment Market Share Calculation 2.6 Model Details 2.7 List of Secondary Sources
Chapter 4 Executive Summary 4.1 Market Outlook 4.2 Market Segment Outlook 4.3 Competition Insight 4.4 Market Snapshot
Chapter 5 Industry Outlook 5.1 Penetration Rate and Growth Prospects Figure 5.2 Market Dynamics 5.2.1 Market Driver Analysis 5.2.1.1 Increase in the Number of Surgical Operations 5.2.1.2 Incidence of Hospital Acquired Infections (HAI) Rising 5.2.1.3 COVID-19 Outbreak Impact 5.2.2 Analysis of market constraints 5.2.2.1 Increase in demand for home care services 5.3 Hospital dress market analysis tools 5.3.1 SWOT analysis, PEST 5.3.2 Porter's five forces analysis
Chapter 6 US Hospital Dress Market: Segmentation Analysis, By Type, 2016-2028 (Millions of USD) 6.1 Definition and Scope 6.2 Type Market Share Analysis, 2020 and 2028 6.3 Hospital Dress Market, By Type, 2016 6.4 Market size forecast analysis by 2028 6.4.1 Surgical gown 6.4.2 Non-surgical gown 6.4.3 Patient gown
Chapter 7 US Hospital Dress Market: Segmentation Analysis, by Availability, 2016 to 2028 (Millions of US Dollars) 7.1 Definition and Scope 7.2 Usability Market Share Analysis, 2020 and 2028 7.3 Hospital Dress Market, by Availability, 2016 Trend forecast and market size forecast to 2028 7.4 Analysis 7.4.1 Disposable gown 7.4.2 Reusable gown
Chapter 8 US Hospital Dress Market: Segmentation Analysis, by Risk Type, 2016-2028 (Millions of USD) 8.1 Definition and Scope 8.2 Risk Type Market Share Analysis, 2020 and 2028 8.3 Hospital Dress Market by Risk Type , 2016 to 2028 8.4 Market size forecast and trend analysis 8.4.1 Lowest risk workwear 8.4.2 Low risk workwear 8.4.3 Medium risk workwear 8.4.4 High risk workwear
Chapter 9 Hospital Dress Market: Competitive Analysis 9.1 Company Profile 9.2 Product Benchmarking 9.3 SWOT Analysis
For more information about this report, please visit https://www.researchandmarkets.com/r/mf2jb2
View the source version on businesswire.com: https://www.businesswire.com/news/home/20211124006115/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com
Call 1-917-300-0470 during EST office hours toll-free number 1-800-526-8630 GMT during office hours in the United States/Canada, dial 353-1-416-8900 during office hours
While large-cap stocks are generally safer, small-cap stocks are often more exciting. If you have the right small-cap stocks, you can make a lot of money as your company becomes tomorrow's large-cap stocks. This Fool.com contributor panel provides brave investors with ideas for three small-cap COVID-19 stocks.
As of 11:51 am EST on Wednesday, Longeveron's (NASDAQ: LGVN) share price has soared 72.9% after more than doubled earlier in the day. An epic brief squeeze seems to be underway. Longeveron announced on November 18 that the US Food and Drug Administration (FDA) granted the experimental drug Lomecel-B the title of rare pediatric disease for the treatment of rare congenital heart defects.
After the U.S. Food and Drug Administration (FDA) issued a warning letter, Owlet has stopped selling its popular Smart Sock series in the United States.
HIV patients who have participated in the trial will continue to receive the combination therapy of these companies.
"This is the most extreme thing I have ever experienced," Emily Skye said when she was born at home in the new episode of the PEOPLE podcast "Me Becoming Mom"
This year should be the year when vaccines control the pandemic. Conversely, more people died of COVID-19 in the United States this year than last year before the vaccine was available. As of Tuesday, the Centers for Disease Control and Prevention has recorded 386,233 COVID-19-related deaths in 2021, compared with 385,343 in 2020. This year’s final number will be higher, not only because there is more than a month left, but also because local institutions need time
There may be a second wave of COVID-19 vaccines. In the hope that the SARS-CoV-2 vaccines of various companies will be widely approved, Novavax (NASDAQ: NVX) has risen nearly 90% so far this year, and Ocugen (NASDAQ: OCGN) at the same time This period has risen by more than 300%. Patrick Bafuma: First, let's take a look at Novavax.
"Obviously, this plan does not have a fail-safe protocol in place," Dr. Nicole Noyes, an IVF expert, told people in this week's question
Surgery to transplant hair from the back of the head to the eyebrows to create a fuller look
South African scientists said they have detected a small number of new COVID-19 variants and are working to understand its potential impact. They said that early signs from diagnostic laboratories indicate that this mutation is rapidly increasing in Gauteng, the most populous province, and may already exist in eight other provinces of the country. This variant has also been found in Botswana and Hong Kong.
The number of new coronavirus cases in Monroe County has surged again. Newest
After being attacked by a dog on November 3, she spent a year looking for a surgeon
More than 30 years ago, Louis Foranoce was diagnosed with diabetes. In 2012, after reaching 400 pounds, he underwent belt surgery.
The Duchess of Cambridge goes back to school to see how the students learn about brain development
Scientists have discovered a potentially dangerous variant of the new coronavirus in South Africa. Researchers there are trying to reverse engineer the Moderna vaccine with the support of the World Health Organization. Deborah Pata reports.
His doctor said in a follow-up memo that the polyp removed from President Joe Biden’s colon last week was a benign, slow-growing but possibly precancerous lesion and no further action was required. The president's physician, Dr. Kevin C. O'Connor, wrote in a memo issued by the White House on Wednesday that the specimen was a tubular adenoma, similar to a specimen taken from Biden in 2008. He wrote that routine monitoring is recommended, and colonoscopy is usually required again within 7 to 10 years.
If you don't spend much on copayments, co-insurance, and deductibles for medical appointments each year, Medigap Plan N may be a good choice.
Enough is enough! View entire post ›
The health care system is facing the fourth wave of pandemic-it turns out that compared with the previous three waves, it takes longer and patients become more ill.
According to the Centers for Disease Control and Prevention (CDC), one person in the United States has a stroke every 40 seconds, and there are more than 795,000 strokes across the country each year. Although they are very common, experts also estimate that 80% of strokes are actually preventable. Under normal circumstances, doctors recommend healthier eating and exercise habits to control blood pressure. But according to one study, another activity may be